Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2249 - 2256 of 11618 results
2021 Trends in Bet-the-Company Class Actions
January 5, 2022| News
When Can a Trademark Owner Take Action for Unauthorized Use of its Trademark Online?
January 4, 2022| Blog| Viewpoint
Patent Cases To Watch In 2022
January 4, 2022| News
Massachusetts Cases To Watch In 2022
January 4, 2022| News
U.S. Auditors to Push Clients on ESG Pledges, Business Strategy
January 4, 2022| News
In-House Counsel’s Role in Bridging the Generation 'We' Gap
January 4, 2022| News
In-House Counsel’s Role in Bridging the Generation 'We' Gap
January 4, 2022| Blog| Viewpoint
New York Department of Labor Issues Proposed Regulations for HERO Act Workplace Safety Committee Requirement
January 4, 2022| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.